Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tymon Pol

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Cardiology|October 16, 2023
Heart failure registries - Future directionsTymon Pol, Patric Karlström, Lars H Lund
Journal of the American College of Cardiology|January 28, 2026
Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023)Daniel Lindholm, Gustav Ribom, Stefan Gustafsson, et al.
Journal of the American Heart Association|January 14, 2026
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart FailureTymon Pol, Johan Lindbäck, Jonas Oldgren, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
Journal of the American Heart Association|December 9, 2020
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial FibrillationZiad Hijazi, Lars Wallentin, Johan Lindbäck, et al.
Cardiovascular Research|August 6, 2021
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillationTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.
Open Heart|March 20, 2021
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areasTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
European Journal of Heart Failure|September 16, 2024
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and designLars H Lund, Stefan James, Adam D DeVore, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Cardiology|October 16, 2023
Heart failure registries - Future directionsTymon Pol, Patric Karlström, Lars H Lund
Journal of the American College of Cardiology|January 28, 2026
Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023)Daniel Lindholm, Gustav Ribom, Stefan Gustafsson, et al.
Journal of the American Heart Association|January 14, 2026
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart FailureTymon Pol, Johan Lindbäck, Jonas Oldgren, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
Journal of the American Heart Association|December 9, 2020
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial FibrillationZiad Hijazi, Lars Wallentin, Johan Lindbäck, et al.
Cardiovascular Research|August 6, 2021
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillationTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.
Open Heart|March 20, 2021
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areasTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
European Journal of Heart Failure|September 16, 2024
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and designLars H Lund, Stefan James, Adam D DeVore, et al.
Pageof 1